Back to results

Massachusetts Institute of Technology

A maturity model for process data analytics in biopharmaceutical manufacturing

Abstract

dc:description.abstract

The Biopharmaceutical industry continues to add a record number of life-saving biological therapies every year, which builds up pressure to make their manufacturing processes faster, more consistent, and more productive. Increased digitalization is expected to address these needs by means of new capabilities related to the analysis of the data collected in the manufacturing process (a.k.a. process data analytics). The objective of this work is to research a framework with which to assess the ability of a Biopharmaceutical company to exploit process data analytics in drug substance manufacturing of monoclonal antibodies. A comprehensive view of the potential benefits of process data analytics is provided, as well as a detailed account of the improvements required to realize those benefits. The framework was built using the published information of analytics use cases, the opinions of experienced practitioners of four major biopharmaceutical companies, and other guidelines built to address similar topics in other industries. Throughout the process, a detailed account of the complexities involved in the deployment of process data analytics was captured and explained. Additionally, four approaches driving the value of analytics for biopharmaceutical processing were identified and used to classify the different use cases. The result is a maturity model of the manufacturing site that describes four archetypical states of process data analytics implementation. They are characterized in terms of the mechanics of value creation and the requirements from informational technology (IT), operational technology (OT), and external sources of information. This model provides the basis upon which biopharmaceutical manufacturers or industry consortiums can further specify its content and generate an assessment tool to guide their manufacturing strategies.

Degree

thesis:*
Name thesis:degree_name
Master
Department dc:contributor.department
Massachusetts Institute of Technology. Engineering and Management Program
Grantor dc:publisher
Massachusetts Institute of Technology
Year dc:date.issued
2021

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Egaña Tomic, Tomas C.
Advisor dc:contributor.advisor
  • Stacy L. Springs and Joan S. Rubin.

Subjects

dc:subject × 2

Rights

dc:rights
Statement dc:rights
  • MIT theses may be protected by copyright. Please reuse MIT thesis content according to the MIT Libraries Permissions Policy, which is available through the URL provided.
Language dc:language.iso
eng

Identifiers

dc:identifier.*
Handle dc:identifier.uri
https://hdl.handle.net/1721.1/132884
OAI identifier oai:identifier
oai:dspace.mit.edu:1721.1/132884

Chain of custody

source
Harvested from
MIT
Base URL
dspace.mit.edu/oai/request
Last updated
2026-07-22
Source record
OAI-PMH GetRecord
citation

Egaña Tomic, Tomas C.. A maturity model for process data analytics in biopharmaceutical manufacturing. Massachusetts Institute of Technology, 2021. https://hdl.handle.net/1721.1/132884